ADE | Burzynski et al. 2015 Antineoplastons A10 and AS2-1 N (%) | Chamberlain et al. [31] 2006 Cyclophosphamide N (%) | Chamberlain et al. [32] 2008 CPT-11 N (%) | Yung et al. [22] 1999 Temozolomide N (%) | ||||
Grade 3 | Grade 4 | Grade 3 | Grade 4 | Grades 3/4 | Grade 5 | Grades 3/4 |
| |
Hypernatremia | 5 (12.5) | 2 (5) |
|
|
|
|
|
|
Hypocalcemia |
| 1 (2.5) |
|
|
|
|
|
|
Hypokalemia | 4(10) | 2 (5) |
|
|
|
|
|
|
Thrombocytopenia |
|
| 5 (12) | 1 (2) | 2 (5) |
| 10 (6) |
|
Neutropenia |
|
| 7 (17) | 1 (2) | 1 (2) |
| 3 (2) |
|
Leukopenia |
|
| 15 (37) | 2 (5) | 1 (2) |
| 3 (2) |
|
Anemia |
|
| 5 (12) |
|
|
| 1 (1) |
|
Asthenia |
|
|
|
| 2 (5) |
| 9 (6) |
|
Fatigue | 1 (2.5) |
| 9 (22) |
|
|
| 7 (5) |
|
Fever |
|
|
|
|
|
| 3 (2) |
|
Peripheral edema |
|
|
|
|
|
| 1 (1) |
|
Weight loss |
|
|
|
|
|
|
|
|
Headache |
|
| 1 (2) |
|
|
| 10 (6) |
|
Convulsions |
|
| 1 (2) |
|
|
| 8 (5) |
|
Dizziness |
|
|
|
|
|
| 1 (1) |
|
Somnolence | 1 (2.5) |
|
|
|
|
| 5 (3) |
|
Suicide attempt |
|
|
|
|
|
|
|
|
Pain | 1 (2.5) |
|
|
|
|
|
|
|
Other neurological ADE* |
|
|
|
|
|
| 2 (1) |
|
Hypertension |
|
|
|
|
|
|
|
|
Syncope |
|
|
|
|
|
|
|
|
Bradycardia |
|
|
|
|
|
|
|
|
Apnea |
|
|
|
|
|
|
|
|
Anorexia |
|
|
|
|
|
| 1 (1) |
|
Constipation |
|
| 1(2) |
|
|
| 1 (1) |
|
Diarrhea |
|
|
|
| 3 (7) | 1 (2) | 3 (2) |
|
Nausea |
|
| 3 (7) |
| 2 (5) |
| 16 (10) |
|
Vomiting |
|
| 2 (5) |
| 4 (10) |
| 10 (6) |
|
Pruritus |
|
|
|
|
|
| 2 (1) |
|
Infection |
|
| 1 (2) |
| 1 (2) |
|
|
|
Thrombophlebitis |
|
| 1 (2) |
| 1 (2) |
|
|
|
Intracranial hemorrhage |
|
|
|
|
|
|
|
|
Bilirubinemia |
|
|
|
|
|
|
|
|
Hyperglycemia |
|
|
|
|
|
|
|
|
Urinary frequency | 1 (2.5) |
|
|
|
|
|
|
|
Urticaria | 1 (2.5) |
|
|
|
|
|
|
|
Basal cell carcinoma |
|
|
|
|
|
|
|
|